Ultragenyx Pharmaceutical Inc. · NASDAQ:RARE

BlackRock, Inc. reported a 8.30% stake in Ultragenyx Pharmaceutical Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Jul 30, 2026

BlackRock, Inc. reported a 8.30% stake in Ultragenyx Pharmaceutical Inc., 8,141,384 shares, as a passive investor on Jun 30, 2026. Filed Jul 30, 2026 (Schedule 13G/A).

Stake
8.30%
Shares
8,141,384
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.8.30%8,141,384

Source

View original at SEC

Related